Effects on drug metabolism of carbaryl and 1-naphthol in the mouse

Handling ability of gaseous microemboli of two pediatric arterial filters in a simulated CPB model.

Perfusion·2013

Glucose consumption by rats decreases cytochrome P450 enzyme activity by altering hepatic lipids.

Life sciences·1999

Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid.

Anticancer research·1993

Glucose alters rat liver S9-mediated mutagenesis, metabolism and DNA-binding of aflatoxin B1.

Cancer letters·1990

Effect of glucose administration on hamster liver S9-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and aflatoxin B1.

Cancer letters·1990

Inhibition of liver microsome-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol in the rat following glucose administration.

Cancer letters·1990

β-Hydroxybutyrate alleviates intestinal aGVHD via remodeling gut microbiota-bile acid axis and inhibiting TLR4-NF-κB-driven Th1/Th17 differentiation.

Life sciences·2026

Inhibition of the MEK-ERK signaling pathway reverses acquired osimertinib resistance in NSCLC attributed to AXL overexpression.

Life sciences·2026

Orai3 deficiency drives atrial remodeling and fibrillation susceptibility via Orai channel remodeling and SOCE hyperactivation.

Life sciences·2026

UDP-glucose ceramide glucosyltransferase (UGCG) is a novel positive regulator of MyD88-driven inflammation in sepsis.

Life sciences·2026

Molecular stratification of ovarian insufficiency via novel MicroRNA signatures and target gene suppression.

Life sciences·2026

Hippo-YAP signaling: A novel pathway regulating platelet activation and thrombogenesis.

Life sciences·2026

NMA plus antitumor therapy versus antitumor therapy alone in patients with BCLC stage B or C hepatocellular carcinoma and pre-cachexia or cachexia: protocol for a prospective, multicenter, randomized, open-label phase II trial.

Frontiers in gastroenterology (Lausanne, Switzerland)·2026

Cannabinoids in oncology: pharmacology, clinical applications, and translational perspectives.

Frontiers in pharmacology·2026

Phytochemicals in colorectal cancer therapy: emerging mechanisms, translational opportunities, and global research evolution.

Journal of materials chemistry. B·2026

Untargeted salivary metabolomics for early prediction of chemotherapy-induced oral toxicities in patients with oral squamous cell carcinoma.

Odontology·2026

Lessons from oncology: Can cancer lead the way in resistance management?

Evolution, medicine, and public health·2026

Cannabis Co-Use and Endocannabinoid System Modulation in Tobacco Use Disorder.

Neuroscience and biobehavioral reviews·2026

Related Experiment Videos

Effects on drug metabolism of carbaryl and 1-naphthol in the mouse

Related Concept Videos

Handling ability of gaseous microemboli of two pediatric arterial filters in a simulated CPB model.

Glucose consumption by rats decreases cytochrome P450 enzyme activity by altering hepatic lipids.

Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid.

Glucose alters rat liver S9-mediated mutagenesis, metabolism and DNA-binding of aflatoxin B1.

Effect of glucose administration on hamster liver S9-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and aflatoxin B1.

Inhibition of liver microsome-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol in the rat following glucose administration.

β-Hydroxybutyrate alleviates intestinal aGVHD via remodeling gut microbiota-bile acid axis and inhibiting TLR4-NF-κB-driven Th1/Th17 differentiation.

Inhibition of the MEK-ERK signaling pathway reverses acquired osimertinib resistance in NSCLC attributed to AXL overexpression.

Orai3 deficiency drives atrial remodeling and fibrillation susceptibility via Orai channel remodeling and SOCE hyperactivation.

UDP-glucose ceramide glucosyltransferase (UGCG) is a novel positive regulator of MyD88-driven inflammation in sepsis.

Molecular stratification of ovarian insufficiency via novel MicroRNA signatures and target gene suppression.

Hippo-YAP signaling: A novel pathway regulating platelet activation and thrombogenesis.

NMA plus antitumor therapy versus antitumor therapy alone in patients with BCLC stage B or C hepatocellular carcinoma and pre-cachexia or cachexia: protocol for a prospective, multicenter, randomized, open-label phase II trial.

Cannabinoids in oncology: pharmacology, clinical applications, and translational perspectives.

Phytochemicals in colorectal cancer therapy: emerging mechanisms, translational opportunities, and global research evolution.

Untargeted salivary metabolomics for early prediction of chemotherapy-induced oral toxicities in patients with oral squamous cell carcinoma.

Lessons from oncology: Can cancer lead the way in resistance management?

Cannabis Co-Use and Endocannabinoid System Modulation in Tobacco Use Disorder.

Related Experiment Videos

Effects on drug metabolism of carbaryl and 1-naphthol in the mouse

Related Concept Videos

Related Articles